Literature DB >> 423330

Pre-estrogen breast irradiation for patients with carcinoma of the prostate: a critical review.

J D Gagnon, W T Moss, K R Stevens.   

Abstract

We studied 38 patients with prostatic cancer who received breast irradiation before oral estrogen administration. Our data are combined with those from other institutions to determine the effectiveness of pre-estrogen breast irradiation in minimizing gynecomastia and/or pain. Based on our review the incidence of estrogen-induced breast changes is 70%. Irradiation given before estrogen administration can prevent or minimize these changes in 89.3% of the treated patients. Histologic changes of gynecomastia are reviewed and recommendations for optimum radiation therapy technique are included.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423330     DOI: 10.1016/s0022-5347(17)56713-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Five-year clinical follow-up of prostatic cancer patients treated with fosfestrol and bromocriptine.

Authors:  L Jeromin; J Wiśniewski; M Rozniecki; Z Janiak; J Borkiewicz
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

2.  Management options for gynaecomastia and breast pain associated with nonsteroidal antiandrogen therapy : case report series.

Authors:  I Leibovitch; D Gillatt; P Hopwood; P Iversen; R E Mansel; D McLeod; R Vela-Navarrete; P Richaud; W See; C Tyrrell; M Wirth
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  Estrogenic side effects of androgen deprivation therapy.

Authors:  Theresa A Guise; Michael G Oefelein; James A Eastham; Michael S Cookson; Celestia S Higano; Matthew Raymond Smith
Journal:  Rev Urol       Date:  2007

Review 4.  Management of complications of prostate cancer treatment.

Authors:  M Dror Michaelson; Shane E Cotter; Patricio C Gargollo; Anthony L Zietman; Douglas M Dahl; Matthew R Smith
Journal:  CA Cancer J Clin       Date:  2008-05-23       Impact factor: 508.702

Review 5.  Drug therapy of prostatic cancer.

Authors:  R P Huben; S D Perrapato
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 6.  Preventing and treating the complications of hormone therapy.

Authors:  Ravi J Kumar; Al Barqawi; E David Crawford
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.